do you have to stay on a glp 1 forever Obesity Meds Forever? Experts Weigh In The Data Are Clear: Patients

Until then, any use outside of a clinical trial setting would be considered off-label and is not currently recommended

The reduced endothelial function has been linked to reduced insulin-mediated nitric oxide production and reduced muscle glucose uptake [3]

It seems to orchestrate a more efficient and organized healing response

The approval of Mounjaro is an exciting step forward for people living with type 2 diabetes given the results seen in these clinical trials. Patrick Archdeacon, MD, associate director of the Division of Diabetes, Lipid Disorders and Obesity within the FDAs Center for Drug Evaluation and Research, also commented on the approval in an agency statement

2022 Feb 14;7(1):48